Cytokine production by leukocytes of Papillon–Lefèvre syndrome patients in whole blood cultures

Cytokine production by leukocytes of Papillon–Lefèvre syndrome patients in whole blood cultures

  • نوع فایل : کتاب
  • زبان : انگلیسی
  • مؤلف : Christian D. Sadik & Barbara Noack & Beate Schacher & Josef Pfeilschifter & Heiko Mühl & Peter Eickholz
  • چاپ و سال / کشور: 2011

Description

Papillon.Lefevre syndrome (PLS) is characterised by aggressively progressive periodontitis combined with palmo-plantar hyperkeratosis. It is caused by پgloss of functionپh mutations in the cathepsin C gene. The hypothesis behind this study is that PLS patientsپf polymorphonuclear leukocytes (PMNs) produce more proinflammatory cytokines to compensate for their reduced capacity to neutralize leukotoxin and to eliminate Aggregatibacter actinomycetemcomitans. Production of more interleukin (IL)-8 would result in the attraction of more PMNs. The aim of this study was to evaluate the cytokine profile in PLS patientsپf blood cultures. Blood was sampled from eight PLS patients (one female) from six families (antiinfective therapy completed: six; edentulous: two) with confirmed cathepsin C mutations and deficient enzyme activity. Nine healthy males served as controls. Whole blood cultures were stimulated with highly pure lipopolysaccharide (LPS) from Escherichia coli R515 and IL-1ƒہ plus tumor necrosis factor (TNF)-ƒ؟. Thereafter, release of IL-1ƒہ (stimulation: LPS and LPS plus adenosine triphosphate), IL-6, IL-8, interferon-inducible protein (IP)-10, and interferon (IFN)-ƒء (stimulation: LPS, IL-1ƒہ/TNFƒ؟) were detected by ELISA. Medians of cytokine release were, with the exception of IP-10, slightly higher for PLS than for controlsپf cultures. None of these differences reached statistical significance. Increased production of IL-1ƒہ, IL-6, IL-8, IP-10, or IFNƒء as a significant means to compensate for diminished activity and stability of polymorphonuclear leukocyte-derived proteases could not be confirmed in this study. Cytokine profiles in blood cultures may not be used to identify PLS patients.
Clin Oral Invest DOI 10.1007/s00784-011-0532-0 Received: 10 June 2010 / Accepted: 18 February 2011
اگر شما نسبت به این اثر یا عنوان محق هستید، لطفا از طریق "بخش تماس با ما" با ما تماس بگیرید و برای اطلاعات بیشتر، صفحه قوانین و مقررات را مطالعه نمایید.

دیدگاه کاربران


لطفا در این قسمت فقط نظر شخصی در مورد این عنوان را وارد نمایید و در صورتیکه مشکلی با دانلود یا استفاده از این فایل دارید در صفحه کاربری تیکت ثبت کنید.

بارگزاری